Impact of US custom policies on the chemical & pharmaceutical industry

USA launches Section 232 investigation into pharmaceuticals

Strengthening free trade, dismantling customs duties

Overview and position on relations with the EU

‘Switzerland seems less “hungry” for competition’

Life Sciences: Switzerland must become more active

Full association with Horizon – why EU research ties matter to CH

Full association to Horizon Europe essential

EU chemicals legislation: Switzerland's pragmatic responses

Differentiated view of "risk versus hazard"

TFA: key facts at a glance

Overview and position on chemicals regulation

The poison and the dose – Great panic over small values?

PFAS: Key facts at a glance

Export bans: International solutions instead of solo national efforts